Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Feasibility of Collateral Information Review and Its Impact on Clinical Decision-Making

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04635748
Recruitment Status : Completed
First Posted : November 19, 2020
Last Update Posted : December 10, 2020
Sponsor:
Collaborator:
Once Upon a Time Foundation
Information provided by (Responsible Party):
Ipsit Vihang Vahia, Mclean Hospital

Brief Summary:
This project will investigate how review of collateral information sources (CIS) may impact clinical decision-making across the lifespan.

Condition or disease
Depressive Disorder Anxiety Disorders

Detailed Description:
This study aims to explore how reviewing collateral information sources (CIS) may affect clinical decision-making for clinicians treating participants with varied mood disorders. Investigators will assess the types of collateral information used in the clinical setting and treatment decisions made after a clinical session. We will gather this information from interested clinicians who will provide this information after each patient visit over the course of one week.

Layout table for study information
Study Type : Observational
Actual Enrollment : 89 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: Feasibility of Collateral Information Review and Its Impact on Clinical Decision-Making
Actual Study Start Date : December 3, 2019
Actual Primary Completion Date : March 14, 2020
Actual Study Completion Date : March 14, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety




Primary Outcome Measures :
  1. Rate of Use of the McLean Treatment Tracking Survey [ Time Frame: Over the course of 1 week ]
    Clinicians will find the McLean Treatment Tracking Survey easy to use in their clinical care.

  2. Rate of Completion of the McLean Treatment Tracking Survey [ Time Frame: Over the course of 1 week ]
    The McLean Treatment Tracking Survey (MTTS) will better reflect collateral information reviewed in a clinical visit, as well as treatment decisions made. Investigators will compare responses from the MTTS with clinical notes recorded in patients' charts.


Secondary Outcome Measures :
  1. Clinical Outcome - Increased treatment decisions made [ Time Frame: Over the course of 1 week ]
    Investigators will explore whether reviewing more collateral information sources leads to more clinical actions taken for treatment.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
- Clinicians from McLean Hospital Outpatient Programs (geriatric, child and adult) and the McLean Behavioral Health Partial Program, which predominantly treat patients with mood disorders.
Criteria

Inclusion Criteria:

  1. Credentialed to provide psychopharmacology or psychotherapy at McLean and Licensed by the State of Massachusetts
  2. Practice pharmacotherapy and either adjunctive or stand-alone evidence-based psychotherapy (e.g., CBT, DBT, supportive psychotherapy, etc.)
  3. Fluent in English

Exclusion Criteria:

  • Clinicians who do not meet the inclusion criteria detailed above

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04635748


Locations
Layout table for location information
United States, Massachusetts
McLean Hospital
Belmont, Massachusetts, United States, 02478
Sponsors and Collaborators
Mclean Hospital
Once Upon a Time Foundation
Investigators
Layout table for investigator information
Principal Investigator: Ipsit V Vahia, MD Mclean Hospital
Principal Investigator: Kerry J Ressler, MD; PhD Mclean Hospital
Layout table for additonal information
Responsible Party: Ipsit Vihang Vahia, Medical Director, Geriatric Psychiatry Outpatient Services, Mclean Hospital
ClinicalTrials.gov Identifier: NCT04635748    
Other Study ID Numbers: 2019P003450
First Posted: November 19, 2020    Key Record Dates
Last Update Posted: December 10, 2020
Last Verified: December 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Disease
Depressive Disorder
Anxiety Disorders
Pathologic Processes
Mood Disorders
Mental Disorders